Debut Plus

₹324

▼ -29.4 -8.32%

As of 23 Oct 2026 · delayed

NSE Listed

Gujarat Themis Biosyn Ltd. (GUJTHEM)

Volume: 9,32,727Avg Vol 1W: 3,62,605.6Avg Vol 1M: 2,82,982.652W Range:₹225.05₹479
NSE BSE www.gtbl.in AI Report
Key Ratios
Checked 3h ago
Market Cap₹4,217 Cr
Current Price₹324
Previous Close₹353.4
High / Low (52w)₹479 / ₹225.05
Volume9,32,727
Avg Vol (1W)3,62,605.6
Avg Vol (1M)2,82,982.6
Stock P/E90.25
Book Value₹58.18
Dividend Yield17%
ROE—
ROA0%
Revenue (TTM)₹168 Cr
Revenue Growth22.1%
Profit Margin25.04%
Total Debt₹162 Cr
Shares Outstanding13 Cr
Face Value₹1
EPS (TTM)₹3.59
P/B5.62
Debt / Equity0.36
50 DMA₹393.57
200 DMA₹358.12
Day change-8.32%
Price Chart
₹324▼ 31.05% · 1Y
₹470₹22796.6L
2025-10-27
2026-10-23

20-day avg volume: 2.8L shares

Pros
  • Pays a dividend yield of 17.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 50% YoY.
  • Stock trades at a high P/E of 90.
Quarterly Results
MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Mar 2026Jun 2026
Revenue₹42 Cr₹39 Cr₹35 Cr₹40 Cr₹38 Cr₹36 Cr₹44 Cr₹44 Cr
EBITDA₹21 Cr₹18 Cr₹14 Cr₹18 Cr₹15 Cr₹12 Cr₹16 Cr₹17 Cr
Net Profit₹16 Cr₹13 Cr₹11 Cr₹13 Cr₹12 Cr₹9 Cr₹11 Cr₹11 Cr
EPS————1.1———
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹38 Cr₹152 Cr₹36 Cr₹42 Cr₹43 Cr₹168 Cr₹44 Cr₹44 Cr
EBITDA₹16 Cr₹66 Cr₹12 Cr₹19 Cr₹18 Cr₹65 Cr₹16 Cr₹17 Cr
Net Profit₹12 Cr₹49 Cr₹9 Cr₹14 Cr₹12 Cr₹47 Cr₹11 Cr₹11 Cr
EPS—4.48———4.28——
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹33 Cr₹64 Cr₹88 Cr₹123 Cr₹166 Cr₹221 Cr₹301 Cr₹503 Cr
Total Liabilities₹14 Cr₹22 Cr₹18 Cr₹19 Cr₹17 Cr₹20 Cr₹53 Cr₹216 Cr
Equity₹19 Cr₹42 Cr₹70 Cr₹103 Cr₹149 Cr₹201 Cr₹248 Cr₹288 Cr
Total Debt————————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹8 Cr₹21 Cr₹55 Cr₹60 Cr₹84 Cr₹108 Cr₹59 Cr
Investing₹-3 Cr₹-2 Cr₹-30 Cr₹-20 Cr₹-55 Cr₹-112 Cr₹-172 Cr
Financing₹2 Cr₹-5 Cr₹-14 Cr₹-13 Cr₹-9 Cr₹26 Cr₹115 Cr
Free Cash Flow₹8 Cr₹21 Cr₹55 Cr₹60 Cr₹84 Cr₹108 Cr₹59 Cr
Shareholding
Promoter 59.33% Institutions 16.45% Public 24.22%
About Gujarat Themis Biosyn Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.

www.gtbl.in ↗
Efficiency & Working Capital
ROCE27.2%
Interest Coverage17.2
Dividend Payout—
Debtor Days134 d
Inventory Days34 d
Payable Days81 d
Cash Conversion Cycle87 d
Working Capital Days168 d
Shareholding Details

As of 2026-09-30

Promoter59.3%
FII3.8%
DII12.6%
Institutions16.4%
Public24.2%
Promoter Pledge0%
No. of Shareholders28,781
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2024Sept 2024Dec 2024Feb 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Aug 2026Sept 2026
Promoters70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%59.3%59.3%
FIIs1.4%1.5%1.4%1.5%1.9%2.5%3%2%1.8%1.8%4.9%3.8%
DIIs1.2%1.2%1.2%1.2%1.2%1.2%1.2%1.2%1.2%1.2%13.8%12.6%
Public26.5%26.5%26.5%26.5%26%25.5%25%26%26.2%26.2%21.9%24.2%
Promoter Pledge3.3%3.3%3.3%3.3%3.3%3.3%3.3%4.5%5.4%68.5%0%0%
No. of Shareholders30,28031,27130,93430,43630,67328,94528,31927,32526,88627,01026,89928,781
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Pharmaceutical Business Group [india] LtdShareholding of Promoter and Promoter Group39%5.07 Cr
Themis Medicare LimitedShareholding of Promoter and Promoter Group17.5%2.28 Cr
Quant Mutual Fund - Quant Manufacturing FundPublic Shareholding7.5%97,28,577
Ayushmat LtdPublic Shareholding2.6%33,21,130
Sachin Dinesh PatelShareholding of Promoter and Promoter Group2.3%30,20,760
Kotak Mahindra Life Insurance Company LtdPublic Shareholding2.2%28,24,859
Bank Of India Flexi Cap FundPublic Shareholding1.6%21,18,645
Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel (trustees Of Vividhmargi Trust)Shareholding of Promoter and Promoter Group0.5%6,60,302
Anay Rupen ChoksiShareholding of Promoter and Promoter Group0%22,852
Nysha Rupen ChoksiShareholding of Promoter and Promoter Group0%22,852
Jayshree D PatelShareholding of Promoter and Promoter Group0%10
Dinesh Shantilal PatelShareholding of Promoter and Promoter Group0%10
Reena S PatelShareholding of Promoter and Promoter Group0%10
Board of Directors
NameDesignationYear
Dinesh S PatelChairman & Non Executive Dir.2026
Sachin D PatelManaging Director2026
Kirandeep MadanIndependent Non Exe. Director2026
Hitesh Dharmasinh GajariaIndependent Non Exe. Director2026
K G AnanthakrishnanIndependent Non Exe. Director2026
NIHAR AJAY PARIKHIndependent Director2026
Rajneesh AnandNon-Exec & Non-Independent Dir2026
Vineet GawankarCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Bulk Drugs for its own & Job Work₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹166 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1251111
Corporate Actions
TypeDateValueRemark
forthcoming2026-09-23Dividend—
dividend2026-09-23₹0.67 (67%)Final
forthcoming2026-08-07Board Meetings—
dividend2025-09-04₹0.67 (67%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202600071723
20260007916
2026000077
Insider / Designated-Person Trades

7 recent disclosure(s)

Pharmaceutical Business Group [India] LtdDisposal · 30,00,000
Mrs.Avantika Vijay AgarwalAcquisition · 5,400
Mrs.Avantika Vijay AgarwalDisposal · 3,704
Ms. Avantika Vijay AgarwalDisposal · 656
Ms. Avantika Vijay AgarwalDisposal · 9,032
Pharmaceutical Business Group India LimitedAcquisition · 38,50,000
Substantial Acquisitions (SAST)

2 disclosure(s)

NULL08/07/2026 - 14/07/2026 · 5,25,000
NULL30/06/2026 - 03/07/2026 · 26,00,000
Company Information
Incorporated1981
ChairmanDinesh S Patel
AuditorGMJ & Co
Investor Email[email protected]; [email protected]
🌐 www.gtbl.in ↗

📍 69/C GIDC Industrial Estate, Valsad Dist, VAPI, Gujarat, 396195

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

GTPL Hathway LimitedGufic BioSciences Ltd.Gujarat Alkalies & Chemicals Ltd.Gujarat Apollo Industries Ltd.Gujarat Gas LimitedGujarat Raffia Industries Ltd.Gulf Oil Lubricants India Ltd.GP Petroleums LimitedGulshan Polyols LimitedGurunanak Agricultur In LimitedGVK Power & Infrastructure Ltd.GE PowerAll “G” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search